Canine Brucellosis Antibody Test Kit D Tec Cb
Lab Reagents
Human IgG antibody Laboratories manufactures the canine brucellosis antibody test kit d tec cb reagents distributed by Genprice. The Canine Brucellosis Antibody Test Kit D Tec Cb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact canine brucellosis test. Other Canine products are available in stock. Specificity: Canine Category: Brucellosis Group: Antibody Test
Tec Antibody |
|||
F54447-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
Tyrosine-Protein Kinase Tec (TEC) Antibody |
|||
20-abx135699 | Abbexa |
|
|
Tec Protein Tyrosine Kinase (TEC) Antibody |
|||
20-abx131503 | Abbexa |
|
|
Tec Protein Tyrosine Kinase (TEC) Antibody |
|||
20-abx131504 | Abbexa |
|
|
Tyrosine-Protein Kinase Tec (TEC) Antibody |
|||
abx011600-100ul | Abbexa | 100 ul | EUR 493.2 |
Tyrosine-Protein Kinase Tec (TEC) Antibody |
|||
abx033645-400ul | Abbexa | 400 ul | EUR 627.6 |
Tyrosine-Protein Kinase Tec (TEC) Antibody |
|||
abx033645-80l | Abbexa | 80 µl | EUR 343.2 |
Canine Parvovirus Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092032-40tests | Abbexa | 40 tests | EUR 427.2 |
D-Nase Test Agar 500gm |
|||
211179 | Scientific Laboratory Supplies | EACH | EUR 265.62 |
Canine Cath-D ELISA Kit |
|||
ECC0703 | Abclonal | 96Tests | EUR 625.2 |
Canine D-La ELISA Kit |
|||
ECD0249 | Abclonal | 96Tests | EUR 625.2 |
Canine D-LDH ELISA Kit |
|||
ECD0250 | Abclonal | 96Tests | EUR 625.2 |
Canine VEGF-D ELISA Kit |
|||
ECV0019 | Abclonal | 96Tests | EUR 625.2 |
CB-TH |
|||
5-00940 | CHI Scientific | 4 x 1mg | Ask for price |
CB 300919 |
|||
A3285-10 | ApexBio | 10 mg | EUR 1036.8 |
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |
CB 300919 |
|||
A3285-5 | ApexBio | 5 mg | EUR 606 |
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |
CB 300919 |
|||
A3285-50 | ApexBio | 50 mg | EUR 3316.8 |
Description: CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft. |